LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

HomeStock ListBaxter International Inc

Baxter International Inc

Closed

Sector Healthcare

40.36 -4.31

Overview

Share price change

24h

Current

Min

40.2

Max

42.14

Key metrics

By Trading Economics

Income

-2.3B

245M

Sales

177M

3.9B

P/E

Sector Avg

604.629

23.904

EPS

0.88

Dividend yield

2.546

Profit margin

6.306

Employees

60,000

EBITDA

31M

780M

Recommendations

By TipRanks

Rating Consensus

Buy

12 Months Forecast

+11.58 upside

Dividends

By Dow Jones

Dividend Yield

Sector avg

2.55%

7.76%

Next earnings

2 May 2024

Next Dividend date

1 Jul 2024

Next Ex Dividend date

30 May 2024

Market Stats

By TradingEconomics

Market Cap

-194M

22B

Previous open

44.67

Previous close

40.36

News Sentiment

By Acuity

26%

74%

50 / 274 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Baxter International Inc chart

Related News

27 Mar 2024, 21:59 UTC

Acquisitions, Mergers, TakeOvers

3M's Healthcare Spinoff Stock Fell. This Is What It's Worth. -- Barrons.com

27 Mar 2024, 09:15 UTC

Acquisitions, Mergers, TakeOvers

3M's Healthcare Spinoff Stock Is Trading. This Is What It's Worth. -- Barrons.com

Peer Comparison

Price change

Baxter International Inc forecast

Price Target

By TipRanks

11.58% upside

12 Months Forecast

Average 45 USD  11.58%

High 54 USD

Low 40 USD

Based on 9 Wall Street analysts offering 12 month price targets for Baxter International Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

3

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

N/A / 42.68 Support&Resistance

Short Team

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

50 / 274 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Baxter International Inc

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.